» Articles » PMID: 37079666

Induction of Lysosomal and Mitochondrial Biogenesis by AMPK Phosphorylation of FNIP1

Abstract

Cells respond to mitochondrial poisons with rapid activation of the adenosine monophosphate-activated protein kinase (AMPK), causing acute metabolic changes through phosphorylation and prolonged adaptation of metabolism through transcriptional effects. Transcription factor EB (TFEB) is a major effector of AMPK that increases expression of lysosome genes in response to energetic stress, but how AMPK activates TFEB remains unresolved. We demonstrate that AMPK directly phosphorylates five conserved serine residues in folliculin-interacting protein 1 (FNIP1), suppressing the function of the folliculin (FLCN)-FNIP1 complex. FNIP1 phosphorylation is required for AMPK to induce nuclear translocation of TFEB and TFEB-dependent increases of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) and estrogen-related receptor alpha (ERRα) messenger RNAs. Thus, mitochondrial damage triggers AMPK-FNIP1-dependent nuclear translocation of TFEB, inducing sequential waves of lysosomal and mitochondrial biogenesis.

Citing Articles

Menin maintains lysosomal and mitochondrial homeostasis through epigenetic mechanisms in lung cancer.

Yuan J, Gu G, Jin B, Han Q, Li B, Zhang L Cell Death Dis. 2025; 16(1):163.

PMID: 40057469 PMC: 11890858. DOI: 10.1038/s41419-025-07489-0.


Redox regulation: mechanisms, biology and therapeutic targets in diseases.

Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.

PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.


CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis.

Wu J, Chen L, Wen P Sci Rep. 2025; 15(1):4298.

PMID: 39905216 PMC: 11794568. DOI: 10.1038/s41598-025-88373-x.


Mitochondrial quality control: a pathophysiological mechanism and potential therapeutic target for chronic obstructive pulmonary disease.

Xu M, Feng P, Yan J, Li L Front Pharmacol. 2025; 15():1474310.

PMID: 39830343 PMC: 11739169. DOI: 10.3389/fphar.2024.1474310.


miRNA-541-5p regulates myocardial ischemia-reperfusion injury by targeting ferroptosis.

Zhao Z, Li B, Cheng D, Leng Y J Cardiothorac Surg. 2025; 20(1):63.

PMID: 39815273 PMC: 11734549. DOI: 10.1186/s13019-024-03260-2.


References
1.
Steinberg G, Carling D . AMP-activated protein kinase: the current landscape for drug development. Nat Rev Drug Discov. 2019; 18(7):527-551. DOI: 10.1038/s41573-019-0019-2. View

2.
Reyes N, Banks G, Tsang M, Margineantu D, Gu H, Djukovic D . Fnip1 regulates skeletal muscle fiber type specification, fatigue resistance, and susceptibility to muscular dystrophy. Proc Natl Acad Sci U S A. 2014; 112(2):424-9. PMC: 4299192. DOI: 10.1073/pnas.1413021112. View

3.
Palmieri M, Impey S, Kang H, di Ronza A, Pelz C, Sardiello M . Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet. 2011; 20(19):3852-66. DOI: 10.1093/hmg/ddr306. View

4.
Babicki S, Arndt D, Marcu A, Liang Y, Grant J, Maciejewski A . Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res. 2016; 44(W1):W147-53. PMC: 4987948. DOI: 10.1093/nar/gkw419. View

5.
Heinz S, Benner C, Spann N, Bertolino E, Lin Y, Laslo P . Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell. 2010; 38(4):576-89. PMC: 2898526. DOI: 10.1016/j.molcel.2010.05.004. View